You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

PAVULON Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Pavulon, and what generic alternatives are available?

Pavulon is a drug marketed by Organon Usa Inc and is included in one NDA.

The generic ingredient in PAVULON is pancuronium bromide. There are six drug master file entries for this compound. Additional details are available on the pancuronium bromide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Pavulon

A generic version of PAVULON was approved as pancuronium bromide by DR REDDYS on July 31st, 1990.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PAVULON?
  • What are the global sales for PAVULON?
  • What is Average Wholesale Price for PAVULON?
Summary for PAVULON
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 59
Patent Applications: 3,123
DailyMed Link:PAVULON at DailyMed
Drug patent expirations by year for PAVULON

US Patents and Regulatory Information for PAVULON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon Usa Inc PAVULON pancuronium bromide INJECTABLE;INJECTION 017015-002 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Organon Usa Inc PAVULON pancuronium bromide INJECTABLE;INJECTION 017015-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PAVULON

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon Usa Inc PAVULON pancuronium bromide INJECTABLE;INJECTION 017015-002 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Organon Usa Inc PAVULON pancuronium bromide INJECTABLE;INJECTION 017015-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for PAVULON

See the table below for patents covering PAVULON around the world.

Country Patent Number Title Estimated Expiration
France 1468539 Nouveaux 2beta, 16beta-diamino-androstanes et procédé pour leur préparation ⤷  Sign Up
Belgium 676708 ⤷  Sign Up
Germany 1593142 ⤷  Sign Up
Netherlands 6602098 ⤷  Sign Up
Switzerland 564565 ⤷  Sign Up
Sweden 343055 ⤷  Sign Up
Brazil 6677320 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.